Summary - MRK - NYSE - Weiss Ratings

C

Merck & Co., Inc. MRK

$77.85 -$0.15-0.19% NYSE

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

52-Week Range

$75.93 - $134.63

P/E (TTM)

EPS (TTM)

My Lists My Alerts

Biotechnology Drugs Health Care Pharmaceutical

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

3/11/2025 - MarketBeat

Merck & Co.: Pipeline Resilience To Unlock Value

4/21/2025 - SeekingAlpha

Merck & Co.: Pipeline Resilience To Unlock Value

4/21/2025 - Seeking Alpha - Long Ideas

Stifel Financial Corp Grows Position in Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - Ticker Report

State of Tennessee Department of Treasury Lowers Holdings in Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - Ticker Report

Select Asset Management & Trust Purchases 790 Shares of Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - Ticker Report

Van Lanschot Kempen Investment Management N.V. Has $178.63 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - Ticker Report

Strength Seen in Lilly (LLY): Can Its 14.3% Jump Turn into More Strength?

4/21/2025 - Zacks Investment Research

Vectors Research Management LLC Has $1.44 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - Ticker Report

Teachers Retirement System of The State of Kentucky Lowers Stock Position in Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - MarketBeat

Mirova Has $324,000 Position in Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - MarketBeat

MML Investors Services LLC Has $49.08 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - Ticker Report

Epoch Investment Partners Inc. Cuts Stake in Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - MarketBeat

First Trust Advisors LP Increases Position in Merck & Co., Inc. (NYSE:MRK)

4/21/2025 - MarketBeat

MetLife Investment Management LLC Grows Position in Merck & Co., Inc. (NYSE:MRK)

4/20/2025 - MarketBeat

Natixis Has $34.78 Million Stake in Merck & Co., Inc. (NYSE:MRK)

4/20/2025 - MarketBeat

Norinchukin Bank The Buys 7,566 Shares of Merck & Co., Inc. (NYSE:MRK)

4/20/2025 - MarketBeat

BI Asset Management Fondsmaeglerselskab A S Reduces Stock Position in Merck & Co., Inc. (NYSE:MRK)

4/20/2025 - MarketBeat

Coastline Trust Co Decreases Position in Merck & Co., Inc. (NYSE:MRK)

4/20/2025 - MarketBeat

Curi RMB Capital LLC Boosts Stock Position in Merck & Co., Inc. (NYSE:MRK)

4/20/2025 - MarketBeat

Dimensional Fund Advisors LP Increases Stock Holdings in Merck & Co., Inc. (NYSE:MRK)

4/20/2025 - MarketBeat

Merck & Co., Inc. (NYSE:MRK) Stock Holdings Cut by Capital Group Private Client Services Inc.

4/20/2025 - MarketBeat

Capital International Inc. CA Decreases Stock Holdings in Merck & Co., Inc. (NYSE:MRK)

4/20/2025 - Ticker Report

Capital International Sarl Has $1.06 Million Holdings in Merck & Co., Inc. (NYSE:MRK)

4/20/2025 - Ticker Report

Institutional Investors Bet $1B on These 4 Stocks—Should You?

3/9/2025 - MarketBeat

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Tuesday, February 25, 2025

Period Date

Tuesday, December 31, 2024

Next Filing

Beginning of May (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Apr 16, 2025 - $75.93

52-week High

Jun 25, 2024 - $134.63

Valuation

Market Cap

$196.28B - Large Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

Dividend Per Share (TTM)

Corporate Info

Website

Phone Number

908 740 4000

Address

126 East Lincoln Avenue
Rahway, NJ 07065

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas... more